- Home
- GANX vs GENK Comparison
GANX vs GENK Comparison
Compare GANX & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- GENK
- Stock Information
- Founded
- GANX 2017
- GENK 2011
- Country
- GANX United States
- GENK United States
- Employees
- GANX N/A
- GENK N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- GENK Restaurants
- Sector
- GANX Health Care
- GENK Consumer Discretionary
- Exchange
- GANX Nasdaq
- GENK Nasdaq
- Market Cap
- GANX 41.9M
- GENK 41.1M
- IPO Year
- GANX 2021
- GENK 2023
- Fundamental
- Price
- GANX $1.85
- GENK $8.29
- Analyst Decision
- GANX Strong Buy
- GENK Strong Buy
- Analyst Count
- GANX 4
- GENK 3
- Target Price
- GANX $7.75
- GENK $13.17
- AVG Volume (30 Days)
- GANX 281.8K
- GENK 58.5K
- Earning Date
- GANX 11-14-2024
- GENK 11-12-2024
- Dividend Yield
- GANX N/A
- GENK N/A
- EPS Growth
- GANX N/A
- GENK N/A
- EPS
- GANX N/A
- GENK N/A
- Revenue
- GANX N/A
- GENK $198,834,000.00
- Revenue This Year
- GANX N/A
- GENK $15.09
- Revenue Next Year
- GANX $300.03
- GENK $20.04
- P/E Ratio
- GANX N/A
- GENK N/A
- Revenue Growth
- GANX N/A
- GENK 12.50
- 52 Week Low
- GANX $0.89
- GENK $5.61
- 52 Week High
- GANX $5.33
- GENK $14.46
- Technical
- Relative Strength Index (RSI)
- GANX 39.86
- GENK 43.52
- Support Level
- GANX $1.64
- GENK $7.62
- Resistance Level
- GANX $2.34
- GENK $10.33
- Average True Range (ATR)
- GANX 0.27
- GENK 0.58
- MACD
- GANX -0.09
- GENK -0.11
- Stochastic Oscillator
- GANX 19.90
- GENK 24.72
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc is an Asian casual dining restaurant in the United States. It offers an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables.